knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 17:05:56 - browse：2

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Cheap, fast test for Zika and dengue could cost just $1

Wikipedia

WSS

Studies point to risks of excluding people with obesity from drug trials

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Pharmacists can make shortage drugs, but at what cost?

UnitedHealth’s board chair also owns a personal investment firm

Curing rare childhood diseases will falter unless Congress steps up

My daughter's legacy lives on through her writing, phage therapy

focus

knowledge

entertainment

23andMe had bad news about my health. I wish a person had delivered it

STAT Virtual Event: ASCO Recap, Live!

State Dept. review finds Biden bears some blame for Afghanistan failures

Curing rare childhood diseases will falter unless Congress steps up

What does generative AI mean for health care? We asked experts

Report captures long Covid’s disabling effects and policy challenges

Hollywood unions extend contract negotiations for actors

STAT Summit: GSK CEO on pharma giant's new direction

Dobbs anniversary: the lost opportunity of abortion as health care

NIH tests clinical research in primary care with $30 million program

explore

Studies point to risks of excluding people with obesity from drug trials

Readers discuss the intersection of pregnancy and addiction

Solve the antibiotic resistance crisis with preventive drugs

Beam Therapeutics to lay off 20% of its staff, re

Moderna says combo Covid

How faith leaders like me can help address America's obesity epidemic

Wikipedia

knowledge

explore

hotspot